Every 8-K that Nature's Sunshine Products Inc. (NATR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow NATR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NATR filings page.
Nature’s Sunshine Products reported second-quarter 2026 results and named Ruth Perkins as Executive Vice President and Chief Financial Officer effective September 1, 2026.
Net sales rose 2% to $117.0 million, with gross margin improving to 73.7%. Operating income increased to $5.5 million, but GAAP net income attributable to common shareholders declined to $3.5 million, or $0.19 per diluted share, while adjusted EBITDA was $11.3 million. The company ended June 30, 2026 with $82.5 million of cash and cash equivalents and no debt, after using $1.0 million of operating cash flow and repurchasing 113,000 shares for $2.6 million.
Management cited 4% constant-currency sales growth and margin expansion, but lowered full‑year 2026 guidance to net sales of $490–$500 million and adjusted EBITDA of $48–$52 million. Perkins’ employment agreement includes a $575,000 base salary, a 70% target bonus, approximately $1.65 million in initial equity awards, relocation support, and severance and change‑in‑control protections.
Nature’s Sunshine Products, Inc. reported that Chief Financial Officer L. Shane Jones has resigned effective June 5, 2026, and stated that his decision was not due to any disagreement over the company’s financial reporting or accounting practices. On May 8, 2026, the company appointed longtime finance executive Jonathan D. Lanoy as Interim Principal Financial Officer. Lanoy currently serves as Senior Vice President, Chief Accounting Officer, and Principal Accounting Officer and has been with the company’s finance organization since 2008. Under an existing employment agreement, he receives an annual base salary of $301,551, a target annual bonus equal to 50 percent of base salary, and may receive 12 months of salary and health coverage continuation if his employment ends under specified conditions.
Nature’s Sunshine Products reported a strong first quarter of 2026, with net sales rising 9% to $122.9 million and GAAP diluted EPS increasing 16% to $0.29. Adjusted EBITDA grew 33% to $14.6 million as gross margin improved to 73.2% and SG&A leveraged slightly on higher sales. All regions delivered sales growth, and the company ended the quarter with $87.6 million in cash and no debt after repurchasing 20,000 shares for $0.5 million. Management reaffirmed its 2026 outlook for net sales of $500–$515 million and adjusted EBITDA of $50–$54 million. Shareholders approved all proxy items, including a new 2026 Stock Incentive Plan reserving up to 1,500,000 shares for equity awards.
Nature’s Sunshine Products reported record 2025 results with strong growth in sales and profitability. Full-year net sales rose 5.7% to $480.1 million, while GAAP net income attributable to common shareholders increased to $19.5 million, or $1.06 per diluted share, from $7.7 million, or $0.40 per diluted share. Adjusted EBITDA grew 21.7% to $49.4 million.
Fourth-quarter net sales rose 4.7% to $123.8 million and GAAP EPS improved to $0.23 from a loss of $(0.02). Q4 adjusted EBITDA increased 16% to $11.9 million. Growth was driven by stronger digital channels and solid performance in North America and key international markets, alongside higher gross margins.
The company ended 2025 with $93.9 million in cash and cash equivalents and no outstanding debt, after repurchasing 1,260,000 shares for $16.3 million. For 2026, it projects net sales between $500 million and $515 million and adjusted EBITDA between $50 million and $54 million. The filing also notes modest base salary increases for the CFO and Executive Vice President, Asia.
Nature’s Sunshine Products, Inc. filed an 8-K announcing it issued a press release with financial results for the first quarter ended September 30, 2025. The release was furnished under Item 2.02 and is attached as Exhibit 99.1.
The company notes the press release includes non-GAAP financial information, with GAAP-to-non‑GAAP reconciliations provided in the release. The information furnished under Item 2.02 is not deemed filed under the Exchange Act.
Nature’s Sunshine Products (NATR) appointed Kenneth Romanzi as Chief Executive Officer and to its Board, effective October 29, 2025. The move follows prior plans for leadership transition and coincides with Terrence O. Moorehead’s resignation on the same date under a separation agreement.
Under an employment agreement dated October 10, 2025, Mr. Romanzi will receive an annual base salary of $850,000, plus eligibility for the executive bonus program. He will be granted RSUs with a fair value of $1,500,000 vesting in equal thirds over three years from the effective date, and performance-contingent RSUs with a fair value of $1,500,000 that vest based on Board-set targets. The agreement provides severance protections, including in connection with a Change in Control event or for Good Reason, as defined.
Mr. Moorehead’s separation includes payments equal to 18 months of estimated base salary, a pro-rated 2025 bonus payable no later than March 15, 2026, and continued vesting treatment for his time-based and performance RSUs during the severance period. The Company furnished a press release announcing the appointment.
Nature's Sunshine Products (Nasdaq:NATR) filed an 8-K announcing a secondary public offering of 2,854,607 shares by major holder Fosun Pharma USA at $12.00 per share (≈$34.3 million to the seller). The company will not receive proceeds but may repurchase up to $15 million of these shares under its existing authorization, with any bought stock cancelled. Closing is slated for 27 June 2025; a 90-day lock-up applies to insiders and the selling stockholder. The underwriting agreement with D.A. Davidson & Co. carries standard terms and indemnities, and any buyback would be funded with cash and the credit facility.